Brian M. Zeglis

8.1k total citations · 2 hit papers
118 papers, 6.4k citations indexed

About

Brian M. Zeglis is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Organic Chemistry. According to data from OpenAlex, Brian M. Zeglis has authored 118 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Radiology, Nuclear Medicine and Imaging, 48 papers in Oncology and 40 papers in Organic Chemistry. Recurrent topics in Brian M. Zeglis's work include Radiopharmaceutical Chemistry and Applications (68 papers), Monoclonal and Polyclonal Antibodies Research (56 papers) and Click Chemistry and Applications (31 papers). Brian M. Zeglis is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (68 papers), Monoclonal and Polyclonal Antibodies Research (56 papers) and Click Chemistry and Applications (31 papers). Brian M. Zeglis collaborates with scholars based in United States, Finland and Canada. Brian M. Zeglis's co-authors include Jason S. Lewis, Jacqueline K. Barton, Valérie C. Pierre, Pierre Adumeau, Thomas Reiner, Lynn C. Francesconi, Melissa A. Deri, Sai Kiran Sharma, Rosemery Membreno and Brendon E. Cook and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Brian M. Zeglis

113 papers receiving 6.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metallo-intercalators and metallo-insertors

2007 761 citations Brian M. Zeglis et al. profile →
PET imaging with 89Zr: From radiochemistry to the clinic

2012 332 citations Brian M. Zeglis, Jason S. Lewis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian M. Zeglis United States	47	3.4k	2.4k	2.3k	2.1k	698	118	6.4k
Charles Eigenbrot United States	46	2.4k 0.7×	2.3k 1.0×	1.6k 0.7×	4.1k 1.9×	622 0.9×	120	8.4k
John F. Valliant Canada	33	3.2k 1.0×	986 0.4×	1.3k 0.6×	821 0.4×	630 0.9×	153	4.5k
Jason P. Holland Switzerland	36	2.6k 0.8×	941 0.4×	968 0.4×	774 0.4×	934 1.3×	132	4.5k
Shuang Liu United States	42	4.2k 1.2×	2.0k 0.8×	522 0.2×	1.4k 0.7×	1.0k 1.5×	127	5.9k
Isabel Santos Portugal	39	2.1k 0.6×	2.0k 0.8×	2.0k 0.9×	837 0.4×	522 0.7×	223	4.8k
António Paulo Portugal	33	1.3k 0.4×	1.2k 0.5×	1.1k 0.5×	823 0.4×	317 0.5×	150	3.1k
Thomas L. Mindt Switzerland	33	1.6k 0.5×	952 0.4×	1.5k 0.7×	1.0k 0.5×	392 0.6×	86	3.4k
Carleen Cullinane Australia	45	812 0.2×	1.9k 0.8×	942 0.4×	2.5k 1.2×	828 1.2×	155	5.2k
Sangeeta Ray Banerjee United States	37	2.4k 0.7×	1.2k 0.5×	394 0.2×	934 0.4×	1.4k 2.1×	93	4.1k
Otto A. Gansow United States	43	3.0k 0.9×	963 0.4×	944 0.4×	1.0k 0.5×	729 1.0×	121	5.5k

Countries citing papers authored by Brian M. Zeglis

Since Specialization

Citations

This map shows the geographic impact of Brian M. Zeglis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian M. Zeglis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian M. Zeglis more than expected).

Fields of papers citing papers by Brian M. Zeglis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian M. Zeglis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian M. Zeglis. The network helps show where Brian M. Zeglis may publish in the future.

Co-authorship network of co-authors of Brian M. Zeglis

This figure shows the co-authorship network connecting the top 25 collaborators of Brian M. Zeglis. A scholar is included among the top collaborators of Brian M. Zeglis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian M. Zeglis. Brian M. Zeglis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scott, Andrew M., Brian M. Zeglis, Suzanne E. Lapi, et al.. (2024). Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics. The Lancet Oncology. 25(6). e250–e259. 20 indexed citations

Houghton, Jacob L., et al.. (2024). MIB Guides: Measuring the Immunoreactivity of Radioimmunoconjugates. Molecular Imaging and Biology. 26(2). 213–221. 1 indexed citations

MacPherson, Douglas, et al.. (2024). Tuning Supramolecular Chirality in Iodinated Amphiphilic Peptides Through Tripeptide Linker Editing. Biomacromolecules. 25(4). 2277–2285. 3 indexed citations

Karlström, Amelie Eriksson, et al.. (2023). Site-Specific Photoaffinity Bioconjugation for the Creation of 89Zr-Labeled Radioimmunoconjugates. Molecular Imaging and Biology. 25(6). 1104–1114. 6 indexed citations

Feng, Yutian, et al.. (2022). Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent. Journal of Medicinal Chemistry. 65(22). 15358–15373. 17 indexed citations

MacPherson, Douglas, et al.. (2022). Leveraging a Dual Variable Domain Immunoglobulin to Create a Site-Specifically Modified Radioimmunoconjugate. Molecular Pharmaceutics. 20(1). 775–782. 1 indexed citations

Sharma, Sai Kiran, Alessandra Piersigilli, Jacob Pourat, et al.. (2021). ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody. Clinical Cancer Research. 28(5). 948–959. 29 indexed citations

Pirovano, Giacomo, Stephen A. Jannetti, Lukas M. Carter, et al.. (2020). Targeted Brain Tumor Radiotherapy Using an Auger Emitter. Clinical Cancer Research. 26(12). 2871–2881. 79 indexed citations

Jannetti, Stephen A., Brian M. Zeglis, Michael R. Zalutsky, & Thomas Reiner. (2020). Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy. Frontiers in Pharmacology. 11. 170–170. 67 indexed citations

10.

Keinänen, Outi, Kimberly Fung, James M. Brennan, et al.. (2020). Harnessing ⁶⁴ Cu/ ⁶⁷ Cu for a theranostic approach to pretargeted radioimmunotherapy. Proceedings of the National Academy of Sciences. 117(45). 28316–28327. 86 indexed citations

11.

Xiao, Gu, et al.. (2020). Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide. Molecular Pharmaceutics. 18(1). 338–346. 3 indexed citations

12.

Imberti, Cinzia, Pierre Adumeau, Júlia Baguña Torres, et al.. (2020). Manipulating the In Vivo Behaviour of 68Ga with Tris(Hydroxypyridinone) Chelators: Pretargeting and Blood Clearance. International Journal of Molecular Sciences. 21(4). 1496–1496. 11 indexed citations

13.

Keinänen, Outi, et al.. (2019). Dual Radionuclide Theranostic Pretargeting. Molecular Pharmaceutics. 16(10). 4416–4421. 27 indexed citations

14.

Membreno, Rosemery, Brendon E. Cook, & Brian M. Zeglis. (2019). Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction. Journal of Visualized Experiments. 10 indexed citations

15.

Sharma, Sai Kiran, Andrew Chow, Sébastien Monette, et al.. (2018). Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models. Cancer Research. 78(7). 1820–1832. 81 indexed citations

16.

Poty, Sophie, Lukas M. Carter, Komal Mandleywala, et al.. (2018). Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 25(2). 868–880. 72 indexed citations

17.

Adumeau, Pierre, et al.. (2018). Thiol-Reactive Bifunctional Chelators for the Creation of Site-Selectively Modified Radioimmunoconjugates with Improved Stability. Bioconjugate Chemistry. 29(4). 1364–1372. 33 indexed citations

18.

Meyer, Jan‐Philip, Paul Kozlowski, Kristen Cunanan, et al.. (2017). Exploring Structural Parameters for Pretargeting Radioligand Optimization. Journal of Medicinal Chemistry. 60(19). 8201–8217. 50 indexed citations

19.

Ulaner, Gary A., Serge K. Lyashchenko, Christopher C. Riedl, et al.. (2017). First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using ⁸⁹Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer. Journal of Nuclear Medicine. 59(6). 900–906. 141 indexed citations

20.

Houghton, Jacob L., Rosemery Membreno, Dalya Abdel-Atti, et al.. (2016). Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry. Molecular Cancer Therapeutics. 16(1). 124–133. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact